Share Name Share Symbol Market Type Share ISIN Share Description
Trakm8 Holdings LSE:TRAK London Ordinary Share GB00B0P1RP10 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 88.00p 85.00p 95.00p - - - 0 07:34:42
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Technology Hardware & Equipment 26.8 0.7 4.5 19.5 31.45

Trakm8 (TRAK) Latest News

More Trakm8 News
Trakm8 Takeover Rumours

Trakm8 (TRAK) Share Charts

1 Year Trakm8 Chart

1 Year Trakm8 Chart

1 Month Trakm8 Chart

1 Month Trakm8 Chart

Intraday Trakm8 Chart

Intraday Trakm8 Chart

Trakm8 (TRAK) Discussions and Chat

Trakm8 Forums and Chat

Date Time Title Posts
20/2/201807:51TRAKm8 Cutting edge Telematics & vehicle management2,347
15/12/201712:51trakm8 - Ultimate Vehicle Control - NEW ISSUE1,486
10/8/201612:22Trakm8 - TW talks crap-
16/2/201615:27Trakm8 - TW says worth jack sheet-

Add a New Thread

Trakm8 (TRAK) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2018-02-19 17:17:0187.0020,00017,400.02O
2018-02-19 15:10:0190.607,3216,632.83O
2018-02-19 14:19:1987.00433376.71O
2018-02-19 14:15:3487.001,000870.00O
2018-02-19 13:20:2489.905,5474,986.75O
View all Trakm8 trades in real-time

Trakm8 (TRAK) Top Chat Posts

Trakm8 Daily Update: Trakm8 Holdings is listed in the Technology Hardware & Equipment sector of the London Stock Exchange with ticker TRAK. The last closing price for Trakm8 was 88p.
Trakm8 Holdings has a 4 week average price of 86p and a 12 week average price of 86p.
The 1 year high share price is 162.50p while the 1 year low share price is currently 62.50p.
There are currently 35,744,254 shares in issue and the average daily traded volume is 53,760 shares. The market capitalisation of Trakm8 Holdings is £31,454,943.52.
she-ra: There seems to be a pattern in Kestrel Partners shareholdings. They seem to build up smallish stakes in somewhat robust growing aim companies and then increase their stakes via placings. What I wonder is, are they encouraging boards to carry out low priced placings to acquire larger stakes on the cheap and which the directors by participating in placings also get shares on the cheap? If it weren't for these placings Kestrel would have to build stakes in the market, like everyone else, and thus share prices of such companies would rise. Instead with placings they benefit by discounted rather than premium prices. The results were good but I didn't see the board doing much of a PR exercise about them. I hope the selling over the last few days isn't insider info leaking aimed at depressing the share price. I just wonder why they have only now after 9 months decided to tell us they had a 'notifiable' stake in Trakm8,
michaelmouse: I've thought long and hard about how to answer the last three posts reasonably succinctly. Here goes:- nod - I bought the majority of my holding in Avesco between prices of 20p-30p. I just rode the waves (with some top-up at 80p), the take-out price was £6.50 with hefty dividends and a £1.10 special along the way. That's because I got to know the company inside out over the years. It always looked cheap. Why on earth would I have traded or top-sliced? I can't predict short term share price movements which are often exacerbated (manipulated) by traders/short sellers. Frankly I don't give a monkey's what they do. Just as well eh? blondeamon - "Very fair point, top slicing is always a prudent strategy." Not always. See above. paulypilot - Your point about the strong cash generation is largely irrelevant. They generated £3.56m however it's accounted for. Net debt has virtually halved at £2.32m and cash has improved to £2.72m, and hence the balance sheet is looking increasingly healthy. I think it'll look even better at the full year. Finally, you say, "It's been rather disappointing to see the recent share price peak at 152p, and now drop back to 107p." Trakm8 are likely to make around £30m in revenues this year. Given that similar companies are being bought for at least 4 times revenues, that suggests fair value for Trakm8 (now) is around £120m or £3.30 per share. Why would an investor with a long view care about short term price fluctuations? Incidentally, I believe that a bid will eventually come at a minimum of £5+. Ride the waves and relax. Good luck.
michaelmouse: I bought all my shares in Trakm8 in the teens in 2011 and it's always been an illiquid company to deal in hence the extreme movements in the share price. It's not the most illiquid I hold though. If you don't like it then don't deal in illiquid micro-caps. I've already expressed my views about Trakm8 in my blog. Quite frankly if Trakm8 achieves its full potential then you won't care whether you paid 10p, 100p or 150p for the shares in the long term. hTTp:// You might like to read post 2963?:-
michaelmouse: 1pi - Interim results were pretty much already known when they released the detailed trading update in October. In my experience, this means results day is often a damp squib for most companies unless there are any additional surprises included. I never try and predict short term movements in a share price and prefer to leave that to traders. One thing for sure though, any contract news and/or trading ahead statements in the next few weeks/months and the share price will make very good progress upwards from these levels. I'm very much in for the long game, and hope for significant share price appreciation.
walbrock82: Brief Update Trakm8 reported an increase in revenue to £14.7m, as operating profit shot up to £806k from £362k, as well as Basic EPS rising to 2.97 pence from 0.88 pence. Looking at Trakm8 divisions, their solutions division saw sales grew to £12.48m (2016: £9.69m), whereas Product Sales amounted to £2.27m (2016: £3.49m), a reduction of 35% on last year. Also, they managed to increase recurring revenue by 17% to £5.48m. They have undrawn credit facility of £3.7m at HSBC, as of 30 September 2017. Management Outlook Management remains optimistic about the second-half by stating they have visibility to support our second half expectations because of substantial new contracts in place. The Board remains confident that the market expectations will be met for the full year. Financials in Detail Although net assets rose to £21.37m from £20.23m, this can be attributed to rising intangible assets of £18.1m from £17.1m. But, the greater than expected net cash profit was attributed by the following: 1). Income tax awarded for R&D tax credit of £1.64m; 2). A cash inflow of £200k from movement in working capital, compared to £1.2m cash outflow last year. Net debt improved to £2.32m from £4.4m, helped by a £2m placing and supported by higher than expected net cash profit. There are two things that concern me, these are: 1). No mentioned dividends and 2). Capitalised development costs rising to £1.76m from £1.45m because there is no explanation what constitute these costs. But the company did capitalise £300k of engineering, sales and marketing expenditure. Overall the results were Okay. To read more on Trakm8, it includes analysis of: 1). Trends in development costs; 2). Quality of shareholders’ equity; 3). Share price pattern; 4). And the list of contract wins and extensions. Then, click
lukead: MICHAELMOUSE BLOG Tuesday, 14 June 2016 Volatile times r1singson - As I'm sure you're well aware, markets are jittery at the moment and Trakm8 is an illiquid stock, expect volatile moves in the share price. I'd never offer advice because everyone has their own unique set of circumstances. Personally, I was a very early buyer of Trakm8 shares and I'm more than happy to keep holding for the foreseeable future. The trading statement was issued at the end of April and made for excellent reading. We know revenues and earnings were in line with expectations for the year end March 2016, and that the outlook for the new financial year is encouraging with strong revenue visibility reflecting the strength of their business model. This confidence is underpinned by a maiden 2p dividend. At today's closing price of 191p the current p/e ratio is around 16, and next year's forecast p/e is 11. Hardly expensive for a high growth stock. As ever, I'll just ignore the noise and volatility and look forward to my dividend payout which represents an approx. 11% return on my original investment and I'm hoping that they may adopt a progressive dividend policy. Good luck to short term traders, but it's buy and hold for me every time. XXXXXXXXXXX Well, we know the unfortunate poster lost a packet , but oh, it could have been so much more, if after reading that blog , he had dedided to stay with TRAK, which at time of blog as tated was 191p MICHAELMOUSE BUYS DUDS.
paleje: 3i say recovery clearly intact and next month's numbers and TU keenly awaited. I think your enthusiasm is well placed Blondie ans should say thanks cos it was a post from you months ago which originally alerted me to the potential. By David Brenchley | Wed, 7th June 2017 - 13:09 Trakm8's big win keeps recovery intact Keeping the faith is sometimes difficult to do, and Trakm8 (TRAK) will have been a frustrating holding for some investors. It's long been an Interactive Investor and City favourite, but has been a source of frustration in recent months. Having been a star for so long after listing on AIM back in 2005 - it surged from 4p in 2009 to a December 2015 high of over £4 - a string of profit warnings wiped out 85% of its value over the next year and a half. However, after a trio of contract wins and extensions last month, the telematics and data supplier's troubles could be over, with March's low of 60p a clear bottom. Trakm8 shares have doubled in value since then and were up as much as 8% Wednesday after agreeing an extension to an existing contract with £175 billion oil major Royal Dutch Shell (RDSB). The deal allows it to expand development of its Smart Charging product and, Trakm8 says, provide Shell with a capability to manage and optimise the charging of electric vehicles, initially for the US market. Trakm8 and Shell have been working together since 2013 through Trakm8's Optimisation business Route Monkey, which helps organisations improve productivity and efficiency. Trakm8 chief executive John Watkins says the deal "extends the ongoing work to cover this financial year and creates a framework for continued collaboration". And it's this extension with regards to Route Monkey, after supermarket chain Iceland recently signed up to use the service until April 2024, that's giving Trakm8 a much needed boost. Long-time fan and house broker finnCap said last week that the Iceland deal, along with contracts signed with Mecalec and Direct Line in the weeks previous, will "all help to reassure investors and underpin current forecasts". "Furthermore, [the Iceland] contract validates the long and expensive programme of acquisitions and developments that Trakm8 has undertaken over the last few years to broaden its portfolio of products and services," analyst Lorne Daniel explained. He adds that a change in approach from Trakm8 is now enabling the firm to secure large fleet contracts "and we expect to see more such services in the year ahead". Trakm8 is a company we have backed before. Edmond Jackson drew attention to what he described as "a contrarian's dream" back in November up at £1.50, but the stock disappointed. Undeterred, Edmond took a second look the day before the Iceland deal was announced last week. He concluded that the unravelling of the share price was due more to "timing and investment than lack of appeal of Trakm8's technology", as evidenced by the raft of recent deals. Pre-tax profit for the full-year 2017 is expected to be much lower than 2016's £3.8 million at just £1 million before shooting back up to £3 million in 2018, according to finnCap's forecasts. At one point, those forecasts stood at £5.9 million and £7.2 million respectively. Adjusted earnings per share look likely to be well down next year at 2.8p, giving it a rather lofty looking forecast price/earnings (PE) ratio of 42 times. Trakm8 has traded on an average historic PE of around 30 times, although that was when earnings were growing fast. Daniel has a target price of 180p on Trakm8 shares, suggesting upside of 53%. The next catalyst will be results and a first-quarter update due early next month, which Daniel expects "should provide greater clarity on the sale of the opportunities for the combined product range". We await them with interest.
elrico: One of your own trolls getting all excited over what, may I ask? My guess...looking a fool. much has TRAK lost in the same period? AVN (his favourite fraud) in the same period has bombed from michaelmouse published buy of 190p and 120p to....wait for it...27p TRAK has faired a little better. Bombed from 290p to 165p. I put it to you michaelmouse, you are in no position to lecture me on my largest holding, especially as my published price is 15p with an average of 26p. The fact you are not able to see one of Aim best opportunities, well, quite frankly comes as no shock to me, given you Trak record. I suspect his OPTI short is not going to plan. michaelmouse9 Oct '16 - 14:03 - 597 of 597 0 0 post 585 - "Anyway let's see what develops, but bargepole territory for me with every extra bit of PR they produce to try and pump up the price." Oh dear!! Same old, same old. Loss making company tries diversionary tactic i.e. "spin-off" story. Share price has lost 40% of it's value in the past year. A desperate PR attempt is made over the weekend to try and pump up the price next week and halt a total collapse. Yawn. I hope it works for holders because that "rolling top" on the chart is a classic. If the share price doesn't rise on Monday (substantially) then 40p here we come. They need a strong share price to get a spin-off IPO away hence the tipsters trying to get the PIs all worked up over the weekend. The facts remain. They are years away from meaningful revenues and profitability. They need shed loads of more cash. Hence the attempt at a "spin-off". Nervous day for holders on Monday. Share price needs to "take off" on strategic pumping campaign. ,...,.................................................... Let's have the real facts michaelmouse. These have been furnished to you before; Fully funded for at least 2 years Cash burn at £100k per month No debt 6 commercial joint venture deals where multi national meet R&D costs First commercial production launch of GoFigure. Hybridan expect revenues in the region of £10m Independent valuation of skinbiotix th OK right to be £250m This is going to demerger before Christmas. OPTI own 51% of skinbiotix No dilution to OPTI, The fact you don't understand the clear advantages of demerger is a clear example if one was needed you just don't understand how the markets work. The fact you don't understand how the skinbiotix IPO will benefit OPTI shareholder, whom will get free shares, again shows your folly, your ignorance of real potential, blinded by your hate for a blogger. Strange as this is, you at least find common ground with your view on another company you love dissing. NANO.
blondeamon: Also falling today are shares in Trakm8 (LSE: TRAK), with the vehicle telematics specialist seeing a fall in its share price of 9% despite no news flow having been released by the company. Clearly, this has been a tough year thus far for Trakm8’s investors, with its share price having fallen by 40% year-to-date. And with investor sentiment showing little sign of improving in the short run, further share price declines cannot be ruled out. Rising profitability Looking ahead, however, Trakm8’s share price could record a strong recovery since the company is expected to report rising profitability over the next two financial years. In fact, Trakm8’s bottom line is forecast to rise by 84% in the current year and by a further 48% in the following financial year. This has the potential, if delivered, to cause a step-change in investor sentiment and with Trakm8 trading on a price-to-earnings growth (PEG) ratio of just 0.3, it seems to offer a relatively appealing risk/reward ratio for less risk averse investors. Https://
jombaston: Given the fuss I thought I should read TW. It seems he has 2 arguments: 1. TRAK overpaid for Route Monkey Is TW saying that they didn't perform due diligence before the acquisition? Really? I don't think TRAK were buying RM just for current profits. In any case, the TRAK share price has fallen by several times the total cost of RM! 2. TRAK did not generate FCF in the last full year numbers And this is news? They have been quite clear about reinvesting into capex and r&d rather than paying a dividend. There is no suggestion of any fraud or accounting irregularities so I'm quite relieved. I think the message is DYOR, rather than buying or selling on tips. You are only helping the tipsters who thrive on publicity!
Trakm8 share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180220 07:53:33